Ketamine-based therapies, including Spravato (esketamine) and intravenous (IV) ketamine, have revolutionized the treatment of treatment-resistant depression (TRD) and other mood disorders. These treatments work primarily through the NMDA
- Home
- |
- Archives: Uncategorized
